Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models
- PMID: 22776331
- PMCID: PMC3815566
- DOI: 10.1016/j.nbd.2012.06.025
Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models
Abstract
Interactions between genetic factors and environmental exposures are thought to be major contributors to the etiology of Parkinson's disease. While such interactions are poorly defined and incompletely understood, recent epidemiological studies have identified specific interactions of potential importance to human PD. In this review, the most current data on gene-environment interactions in PD from human studies are critically discussed. Animal models have also highlighted the importance of genetic susceptibility to toxicant exposure and data of potential relevance to human PD are discussed. Goals and needs for the future of the field are proposed.
2012 Elsevier Inc. All rights reserved
References
-
- Agundez JA, et al. Association between the oxidative polymorphism and early onset of Parkinson’s disease. Clin Pharmacol Ther. 1995;57:291–8. - PubMed
-
- Agundez JA, et al. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson’s disease. Neurology. 1998;51:1587–92. - PubMed
-
- Akhmedova SN, et al. Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson’s disease. J Neurol Sci. 2001;184:179–82. - PubMed
-
- Alvarez-Fischer D, et al. Characterization of the striatal 6-OHDA model of Parkinson’s disease in wild type and alpha-synuclein-deleted mice. Exp Neurol. 2008;210:182–93. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
